Follow us :

ent instrument

time2011/12/08

 The 1-year placebo-controlled randomized trial of 709 patients from 22 centers in China also found that COPD treatment using carbocisteine, a relatively cheaper mucolytic drug, can reduce treatment costs by 85 percent, the report said.ent instrument An article on the website of the Lancet journal noted that COPD is predicted to cause 65 million deaths in China between 2003 and 2033. Hence, the work of Zhong and his colleagues has important implications for treating COPD in developing countries.Chronic obstructive pulmonary disease (COPD) is a lung ailment that is characterized by a persistent blockage of airflow from the lungs. The most common symptoms of COPD are breathlessness (or a "need for air"), abnormal sputum (a mix of saliva and mucus in the airway), and a chronic cough.